Vivax Working Group (VxWG)
The aim of the Vivax Working Group (VxWG) is to develop and coordinate operational research that will provide the evidence base for the successful control and ultimate elimination of P. vivax in APMEN Country Partners and the greater Asia-Pacific.
Objectives:
- Identify knowledge gaps and operational research priorities necessary for the optimal control and elimination of vivax malaria
- Share research and operational experience between APMEN Country Partners to maximise synergistic activities and minimise unnecessary duplication
- e.g. study design, standard operating procedure and other research methodologies.
- A document reviewing research activities, assets, collaborators currently being undertaken in Country Partners.
- Fund catalytic research projects to address key knowledge gaps, and facilitate their implementation, analysis and feedback to the Network.
- Develop partnerships with key stakeholder involved in the regional elimination for vivax malaria (including but not limited to WHO, Malaria Atlas Project (MAP), WorldWide Antimalarial Resistance Network (WWARN), Malaria Elimination Group (MEG), Foundation for Innovative New Diagnostics (FIND), Asian Vivax Network, research institutions, funding bodies) in order to:
- Facilitate surveillance strategies to define, monitor, and collate the burden of vivax in APMEN Country Partners.
- Provide evidence for rational diagnostic and treatment guidelines for P. vivax.
- Work with APMEN Country Partners and Partner Institutions to develop a series of integrated translational research programs, apply for external funding and facilitate their implementation.
- Work through APMEN to advocate for improved funding of P.vivax control and research activities.
- Promote collaborative research partnerships amongst APMEN Country Partners
--------------------------------------------------------------------------------------------------------------------------------------
Vivax Working Group links
VxWG Objectives and Governance
VxWG Terms of Reference
Malaria Journal (2013, 12:112): Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report
Workshop Report - Planning a Multicentre Primaquine Trial, 26-28 September, 2011
2012 Vivax Working Group Meeting - Incheon, ROK
2011 Vivax Working Group Meeting - Kota Kinabalu, Malaysia